Save the Date…

25th ESGLD Workshop

Due to the current situation in Israel, the ESGLD Board Members have made the difficult decision to cancel the 25th ESGLD Workshop and Graduate Course, which was due to be held in November 2024.

Although this situation is unavoidable, we do not wish for ESGLD Members to miss out on an opportunity for networking, learning, and discussing in 2024.

We have been able to arrange an exclusive offer to attend the International FOR2625 Symposium on LYSOSOMES & AUTOPHAGY from June 6th to 7th, 2024 in Berlin, Germany. In addition we plan to have an ESGLD exclusive meeting at a nearby venue on the preceeding day.

We therefore invite you to save those dates and join us in Berlin.

LYSOFOR2625 Symposium

The members of the DFG-funded Research Unit FOR2625 – Mechanisms of Lysosomal Homeostasis invite scientists from all over the world to join our second and final International FOR2625 Symposium on LYSOSOMES & AUTOPHAGY from June 6 – 7, 2024 in Berlin, Germany.

We are excited to share once more an unique meeting with you, learning and discussing about the newest findings on the molecular machinery of the endo-lysosomal system and autophagy. As in 2022, our symposium offers a great opportunity for young and more advanced researchers to meet internationally renowned experts and discuss their projects during scientific sessions as well as during social events.

ESGLD - One Day Compact Meeting Venue

Wednesday June 5th (10.00am until 9.00pm): One day compact meeting “New insight into the pathophysiology of lysosome-related diseases” for ESGLD members at the IBIS Style Hotel in Berlin.

We have organised a venue for max. 80 participants, including all services, lunch, and dinner. After registration and abstract submission, the ESGLD Executive Board will put together an attractive program consisting of oral presentations only. Submitted abstracts, which will be selected as posters, can be presented at the subsequent LYSOFOR2625 event.

This meeting will provide a unique opportunity to meet and exchange with other ESGLD member researchers/clinicians. The ESGLD offers travel support in cases where a suitable application is submitted, containing a letter of motivation and a detailed cost plan.

LYSOSOMES & AUTOPHAGY

LYSOSOMES & AUTOPHAGY will take place at the Max Delbrück Communications Center (MDC.C), one of the most modern congress centers in Berlin. The MDC.C is located in the North-East of Berlin on the Campus Berlin-Buch, the largest Biotech Campus in Berlin, and is well connected with the public transportation system.

We are very much looking forward to welcoming you in Berlin in 2024!

25th ESGLD Workshop

Due to the current situation in Israel, the ESGLD Board Members have made the difficult decision to cancel the 25th ESGLD Workshop and Graduate Course, which was due to be held in November 2024.

Although this situation is unavoidable, we do not wish for ESGLD Members to miss out on an opportunity for networking, learning, and discussing in 2024.

We have been able to arrange an exclusive offer to attend the International FOR2625 Symposium on LYSOSOMES & AUTOPHAGY from June 6th to 7th, 2024 in Berlin, Germany. In addition we plan to have an ESGLD exclusive meeting at a nearby venue on the preceeding day.

We therefore invite you to save those dates and join us in Berlin.

5-7 June, 2024 – Berlin

ESGLD Labs/Groups

European Study Group on Lysosomal Diseases
– Promoting Collaboration and Exchange

Winter lab

Winter lab

Nussallee 11
Bonn
DE-NW
53115
DE
Dominic Winter - dominic.winter@uni-bonn.de

TIGEM - Sorrentino

TIGEM - Sorrentino

Piazzetta dell'arco, 7
81030
Succivo
CASERTA
Italy

Maria Cretella - m.cretella@tigem.it

Tromso Lysosomal Research Group

Lysosomal Research Group

UiT, the Arctic University of Norway
9013 Tromso
Norway

Ole Kristian Greiner-Tollersrud - ole.k.tollersrud@uit.no

Tikkanen Lab

Tikkanen Lab

Friedrichstraße 24, Institute of Biochemistry
Giessen
DE-HE
35392
DE
Dr Ritva Tikkanen - ritva.tikkanen@biochemie.med.uni-giessen.de

 

University Medical Center Göttingen - AG Gärtner

University Medical Center Göttingen - AG Gärtner

Georg-Dehio-Weg 7
Göttingen
DE-NI
37075
DE

Lina Schmidt - lina.schmidt@med.uni-goettingen.de

 

Research group Anne Spang

Research group Anne Spang

Spitalstrasse 41
Basel
BS
4056
CH
Viktória Morales-Szentgyörgyi - viktoria.szentgyoergyi@unibas.ch

Sahlgrenska University Hospital, Clinical Chemistry

Sahlgrenska University Hospital, Clinical Chemistry

Sahlgrenska University Hospital, Clinical Chemistry,
Bruna stråket 16
Gothenburg
41345
SE
Maria Blomqvist - maria.k.blomqvist@vgregion.se

BALLABIO - Alessia Calcagni

BALLABIO

Via Varese 16B
Roma
RM
00185
IT
Alessia Calcagni - inviofatture@telethon.it

Stauber Lab

Stauber Lab

Am Kaiserkai 1
Hamburg
20457
DE
Tobias Stauber - tobias.stauber@medicalschool-hamburg.de

BALLABIO - Irene Sambri

BALLABIO

Via Varese 16B
Roma
RM
00185
IT
Irene Sambri - inviofatture@telethon.it

Feldman laboratory

Feldman laboratory

685 West Baltimore Street, HSF-1, Room 380
Baltimore
MD
21201
US
Ricardo A Feldman - rfeldman@som.umaryland.edu

Cell Growth Control in Health and Age-related Disease

Cell Growth Control in Health and Age-related Disease

Joseph-Stelzmann Str., 9b
Cologne
DE-NW
50931
DE
Stephanie De Alcantara Fernandes - sfernandes@age.mpg.de

NOTES:
Cell Growth Control in Health and Age-related Disease

Charles University, Lysosomal group of the Research Unit for Rare Diseases

Charles University, Lysosomal group of the Research Unit for Rare Diseases

Charles University, First Faculty of Medicine, Lysosomal group of the Research Unit for Rare Diseases, Department of Paediatrics and Inherited Metabolic Disorders
Katerinska 32
Prague
Czech Republic
12108
CZ
Ladislav Kuchar - michaela.sosnova@lf1.cuni.cz

Lübke - Bielefeld

Lübke - Bielefeld

Universitätsstr. 25
Bielefeld
DE-NW
33615
DE
Torben Lübke - torben.luebke@uni-bielefeld.de

NCL Research Group

NCL Research Group

Martinistrasse 52
Hamburg
DE-HH
20246
DE
Angela Schulz - anschulz@uke.de

SPPIN Membrane Dynamics Group

SPPIN Membrane Dynamics Group

45 rue des Saints-Pères, CNRS UMR8003
Paris
75006
FR
Bruno Gasnier - bruno.gasnier@u-paris.fr

BioDiscovery Laboratory

BioDiscovery Laboratory

Rua Coronel Corte Real 311, Ap 802
Porto Alegre
RS
90630-080
BR
Roberto Giugliani - roberto.giugliani@gmail.com

Institute of Child Health, Department of Enzymology and Cellular Function

Institute of Child Health, Department of Enzymology and Cellular Function

Thivon 1 and Papadiamantopoulou street
Athens
I
11527
GR
Marina Moraitou - ecfdept@ich.gr

Eskelinen group

Eskelinen group

Kiinamyllynkatu 10, Medisiina C 341
Turku
20520
FI
Eeva-Liisa Eskelinen - eeva-liisa.eskelinen@utu.fi

Secció lo d'Errors Congènits del Metabolisme-IBC

Secció lo d'Errors Congènits del Metabolisme-IBC

C/Mejía Lequerica s/n Ed.Helios III Planta Baja
Barcelona
B
08028
ES
Sonia Pajares - spajares@clinic.cat

Lysosomal Storage Diseases: mechanisms and therapies

Lysosomal Storage Diseases: mechanisms and therapies

Instituto Nacional de Saúde Dr. Ricardo Jorge, Rua Alexandre Herculano, 321
Porto
4000-055
PT
Sandra Alves - sandra.alves@insa.min-saude.pt

NOTES:
Lysosomal Storage Diseases: mechanisms and therapies
In the Lysosomal Storage Diseases: mechanisms and therapies group, research take place from the biochemical and molecular basis of these diseases to the development of RNA therapies as well as to the generation of disease cell models from cells derived from patients. Currently, two major research lines are being developed. 1) Cellular models for the study of lysosomal dysfunction and correction mechanisms and 2) Application of RNA therapies to exploit alternative therapies for lysosomal storage diseases: in vitro and in vivo studies.

The ultimate goal of our research is the design of personalized medicine therapeutic approaches for individuals with rare diseases, which depends directly on clarifying the molecular basis of the disease in each one.

Laboratory of Intracellular Trafficking Biology

Laboratory of Intracellular Trafficking Biology

61 rue de Bruxelles
Namur
5000
BE
Marielle Boonen - marielle.boonen@unamur.be

Pavone LAB

Pavone LAB

Viale Colli Aminei 36
Naples
NA
80131
IT
Luigi Michele Pavone - luigimichele.pavone@unina.it

Lymphocyte Activation Lab

Lymphocyte Activation Lab

Tykistökatu 6
Turku
20520
FI
Pieta Mattila - pieta.mattila@utu.fi

NOTES:
I am the group leader of our lab, which would be a new group to ESGLD, but as lysosomes are only one aspect of our research, I now selected "individual" membership type. But we could be registered as a new group too, depending on your policies.
I am attending the lysosome meeting in Berlin, and would be happy to also join the ESGLD meeting the day before.

Jabs Lab

Jabs Lab

Schwanenweg 20, U27
Kiel
24105
DE
Sabrina Jabs - s.jabs@ikmb.uni-kiel.de

Scuola Normale Superiore Lab NEST


Scuola Normale Superiore Lab NEST


Scuola Normale Superiore and Istituto Nanoscienze - CNR @ NEST (National Enterprise for nanoScience and nanoTechnology)
Piazza San Silvestro 12


56127

PISA

Italy

European Study Group on Lysosomal Diseases

Promoting Collaboration and Exchange

ESGLD New Year 2024 Announcement - Posted 9th January 2024

ESGLD New Year 2024 Announcement

 

Dear Friends of the ESGLD,

You are receiving this New Year email to inform you about a few developments within our ESGLD society. We appreciate your interest and would be extremely happy if you would take some time to have a look at our activities planned for 2024 and an important membership request:

  • The planned meeting in 2024 in Israel was cancelled due to the current situation in the region and we hope - when the situation allows us - to host an ESGLD meeting in the coming years in Israel.
  • As an alternative possibility to meet with the friends or colleagues of our society in 2024, we are able to offer a very attractive package of events related to lysosome biology and lysosomal diseases in Berlin from June 5th until June 7th, 2024. This package consists of an ESGLD members only event as well as admission to the LYSOFOR2625 Symposium:

1.   Wednesday June 5th (10.00am until 9.00pm): One day compact meeting “New insight into the pathophysiology of lysosome-related diseases” for ESGLD members at the IBIS Style Hotel in Berlin. We have organised a venue for max. 80 participants, including all services, lunch, and dinner. After registration and abstract submission, the ESGLD Executive Board will put together an attractive program consisting of oral presentations only. Submitted abstracts, which will be selected as posters, can be presented at the subsequent LYSOFOR2625 event. This meeting will provide a unique opportunity to meet and exchange with other ESGLD member researchers/clinicians. The ESGLD offers travel support in cases where a suitable application is submitted, containing a letter of motivation and a detailed cost plan.

2.   Thursday June 6th and Friday June 7th: A two day meeting on fundamental aspects of lysosome biology. This meeting is organized by the DFG Research Unit 2625 entitled “Mechanisms of Lysosomal Homeostasis” and is open to the public. However, an exclusive contingent of seats at this meeting is reserved for ESGLD members. Registration can be performed via https://lysosomes2024.de/. Meeting information can be found here: https://lysosomes2024.de/. This meeting will take place at the Max Delbrück Communications Center (MDC.C), one of the most modern congress centres in Berlin. The MDC.C is located in the North-East of Berlin on the Campus Berlin-Buch, the largest Biotech Campus in Berlin, and is well connected with the public transportation system.

Confirmed speakers for the LYSOFOR2625 meeting are: MONTHER ABU-REMAILEH – Stanford University, USA; ANDREA BALLABIO – Telethon Institute of Genetics and Medicine, Pozzuoli/Naples, Italy; JUAN BONIFACINO – National Institutes of Health, Bethesda, USA ; JAN CARETTE – Stanford University, USA; CONSTANTINOS DEMETRIADES – Max Planck Institute for Biology of Ageing, Cologne, Germany; SERGIO GRINSTEIN – University of Toronto, Canada; CHRISTIAN HÜBNER – University Hospital Jena, Germany; RUSHIKA PERERA – University of California, San Francisco, USA; DEJIAN REN – University of Pennsylvania, Philadelphia, USA; GIA VOELTZ – University of Colorado – Boulder, USA; MENG WANG – Baylor College of Medicine, Houston, USA.

For ESGLD members, two opportunities exist for participation with these events: Either the FOR2625 event alone (costs: approx. 300 €) or the combined event with the Wednesday ESGLD meeting (total costs of 350 € registration fee for both meetings). In this combined package, you will get both a first- class program and a unique opportunity to network and present your data: oral presentation at the June 5th meeting or/and poster at the FOR2625 event. Accommodation (e.g., hotel, hostel, Airbnb) must be organised individually.

Stay tuned for updates, we will inform you about the exact details on how and when to register in due time (most likely from end of January until March 31st, 2024).

Last but not least, we wish you a very Happy New Year 2024.

Dominic, Paul and Pim

ESGLD board membership election - Posted 6th February 2023

ESGLD board membership election:

With Andrea Ballabio and Eeva-Liisa Eskelinen both standing down from the board we have two places available. After asking for nominations from the membership the following two candidates were proposed and seconded.

Nicole Maria Muschol (muschol@uke.de) – Proposed by Brian Bigger, Seconded by Paul Saftig
Nicolina Cristina Sorrentino (sorrentino@tigem.it) – proposed by Brian Bigger, seconded by Pim Pijnappel

Please read their info below and if you are happy with their candidacy vote for them to join the board, we have two places available so both Nicole and Nicolina will be welcome additions. Voting will close on the 7th February at Noon UK Time.

Nicole Maria Muschol

Nicole Muschol is a paediatrician and metabolic specialist. She is head of the lysosomal working group and spokeswoman of the International Center for Lysosomal Disorders (ICLD) at the University Medical Center Hamburg-Eppendorf in Germany. She is interested in basic science and clinical research, especially in MPS III and mucolipidosis and has been principal investigator or actively involved in many international clinical trials for lysosomal storage disorders.

Nicolina Cristina Sorrentino

Nicolina Cristina Sorrentino was graduated with honors in Biology Science at University of Naples “Federico II”. After working as fellow at the Telethon Institute of Genetics and Medicine of Naples (TIGEM), she started a PhD in “Life and biomolecular Sciences“ at Open University. Her main research interest is the development of new therapeutic strategies for the treatment of inherited neurodegenerative disorders.

In Memoriam: Prof. Dr. med. Michael Beck - Posted 1st November 2022

In Memoriam:  Prof. Dr. med. Michael Beck

Prof. Dr. med. Michael Beck

Obituary – Georg Schetter

Shortly before this year’s Family Conference, we received the sad news that Prof. Dr. Michael Beck passed away unexpectedly on 6.9.2022.

Michael Beck would have been at the Family Conference as he has been for so many years. He would have taken part in the panel discussion this year, he would have had many conversations as always. Together we would have celebrated and we would have toasted his 75th birthday. All that has now turned out quite differently.

We have all been deeply affected by the unexpected death of Michael Beck. Many know Michael Beck because of his work as an outstanding physician – the “Villa Metabolica” will always be associated with his name – , as a teacher of many such wonderful doctors who are at our side today, and not least as a human being.

Today, so many things seem self-evident to us. There are therapies, new therapeutic approaches, an active research community and a vibrant MPS Society. In 1986, the year we were founded, things looked very different. Back then, there was nothing. Scientists and doctors had to be won over to deal with these so rare disease patterns, to do research and to develop therapies. Patient care had to be established and the enthusiasm of young doctors for metabolic diseases had to be awakened, as well as teaching had to be built up. Michael Beck has played a decisive and driving role in ensuring that an international community of scientists, doctors and MPS sufferers has dedicated itself to the topic of MPS. We cannot thank Michael Beck enough for this. Behind it all is not only a scientific and medical interest and a vocation. There is also an enormous private commitment behind it. For example, Michael Beck had a very special connection to us as the MPS Society, because he had been on the board of the MPS Society for many years in various positions since 1988.

It has affected us all deeply that Micheal Beck passed away so unexpectedly and so early. We have lost one of the great and important personalities of our German and international MPS community.

Dear Michael, we owe you so much. We miss you. You will always have a firm place in our community.

Yours, Georg, on behalf of the German MPS Society

In Memoriam: Prof. Dr. Eduard Paschke - Posted 1st November 2022

In Memoriam: Prof. Dr. Eduard Paschke

Prof. Dr. Eduard Paschke – 04.05.1949-14.07.2022

Obituary – Barbara Plecko – Silvija Tokic – Werner Windischhofer

Dear friends and colleagues,

It is with great sadness that, we wish to inform you that Prof. Eduard Paschke died unexpectedly of a heart attack on July 14th. We still can hardly believe his sudden death.

Eduard received his PhD in 1975 in clinical biochemistry in Prof. Hans Kresse ́s Lab at the Institute of Medical Chemistry in Graz, Austria. In 1979 he followed him to Münster where his research work focused on lysosomal metabolism. After returning to Graz in 1982 he founded the Laboratory of Metabolic Diseases at the Department of Paediatrics and Adolescent Medicine in close collaboration with Prof. Adelbert A. Roscher, Prof. Sylvia Stöckler and Prof. Wolfgang Erwa. From 1987 on he was the head of the research group for Biochemistry and Inborn errors of metabolism at our Children ́s University Hospital in Graz.

In the 1990s, Eduard made significant contributions to the molecular characterization of GM1 gangliosidosis versus Morquio B disease. For many years, actually decades, Eduard Paschke participated and contributed to the annual meeting of the Austrian MPS society, in collaboration and friendship with Michaela Weigl, Prof. Susanne Kircher and the MPS community. Eduard thus exemplified translational research long before this term was coined. He also had the foresight to implement genetic diagnostics and analytical techniques in the mid-nineties, along mass spectrometry for the determination of new biomarkers at our diagnostic laboratory in cooperation with Prof. Wolfgang Erwa and PD Günter Fauler. This enabled a comprehensive view of the individual patient’s phenotype, the metabolite pattern, residual enzyme activity and underlying genotype. His last active professional years until his retirement in 2014 he devoted to a joint research project with Prof. Tanja Wrodnigg and Prof. Arnold Stütz (Univ. of Technology Graz) on the development of
pharmacological chaperones as a mutation-specific therapy for lysosomal diseases. Concerning his employees, Eduard always had an open mind and heart as well as high social competence for the creation of new perspectives.

An unforgettable highlight of Eduard’s academic vita was the organization of the World MPS Conference in Vienna in 1999 together with Prof. Susanne Kircher and lastly the ESGLD Meeting in Seggau in 2013 as a farewell to the international LSD community.

As a private person Eduard was always in a good mood and very approachable. He preferred to spend the summers in his Greek adopted country, together with his beloved wife Dagmar and his three children and grandchildren. They have our deepest sympathy.

We will miss Eduard very much, not only in Graz, but certainly also in the circle of the Austrian working group for inborn errors of metabolism, and we will always honor his service to our department and to LSD patients and families. Eduard’s work in highly specialized lab-diagnostics and basic research will be continued with full enthusiasm by his successors and the whole team at our metabolic center.

On behalf of the entire Graz metabolism team,
Barbara Plecko, Silvija Tokic, Werner Windischhofer

24th ESGLD Workshop and Graduate Course … Quick Report - Posted 1st October 2022

24th ESGLD Workshop and Graduate Course
… Quick Report

We’ve had some great teachers,
we learnt a lot,
we scratched our heads a lot!

You had a flash talk task,
and little time to complete it,
“a bit” of stress,
but you all did a brilliant job!

We had excellent talks,
and some very democratic judges (!).

We explored caves, aqueducts,
and you made it to the castle somehow!

Some of you can still play ping-pong, pool and darts after a few drinks,
some of us not so good afterwards..

We made tons of new friends,
looking forward to new collaborations,
and who knows…
the DJ might still show up one day

It’s been a blast!

See you in 2024.

On behalf of the organising committee.
Tereza Andreou

#seeyouinIsrael

Thank you to Brian, Susannah, Laura, Stuart, Shaun, Fabio and Jan for contributing photos.

ESGLD are seeking… New Board Members… - Posted 1st September 2022

ESGLD are seeking…
New Board Members…

Dear ESGLD Members,

I hope you are all well and those who attended enjoyed our recent workshop and graduate course!

I am writing to inform you that two of our long standing board members have decided to step down and therefore we would like to invite the membership to propose new ESGLD board candidates. The plan will be to hold an AGM in December (date tbc) and ask the members to vote for their preferred candidates. If you have someone that you would like to propose please email susannah.james@manchester.ac.uk who will compile a list of candidates. It is essential that each candidate has a proposer and a seconder so please include both on your email.

The ESGLD Board would like to sincerely thank Prof. Eeva-liisa Eskelinen and Prof Andrea Ballabio for all their hard work on the board over the last few years.

I would also like to let the membership know that I have decided to step down as Chairman after 9 years in post. I will continue on the ESGLD board but feel it is time for a new chairperson to guide the group going forward. I will stay as caretaker chairman until a new chair is appointed.

Best Regards
Brian Bigger, ESGLD Chair

A Big Thank You - Posted 1st September 2022

A Big Thank You

We would like to say a big THANK YOU to everyone who participated in the recent 24th ESGLD Workshop and Graduate Course. It was great to have an in-person meeting again to discuss our science and meet old (and new) friends.

We would like to take this opportunity to congratulate our Prize Winners once again!
Best Oral Presentations:
Catarina Pechincha – The lysosomal enzyme trafficking factor LYSET enables nutrient generation from extracellular proteins.
Fabio Catalano – Brain targeting of GAA Promotes Full Correction of Murine Pompe Disease at a Clinically Relevant Dosage of Lentiviral Gene Therapy.
Edoardo Ratto – Direct control of lysosomal catabolic activity by mTORC1 through regulation of V-ATPase assembly.

Best Poster:
Jan van der Beek – Loss of the HOPS complex induces hybrid early-late endosomes that accumulate endocytic, biosynthetic and autophagic cargo.

Best Flash talk groups exercise:
Catarina Pechincha, Drosos Katsavelis, Anastasia Laudicina

See you in Israel in 2024!

On behalf of the organising committee,
Tereza Andreou

24th ESGLD Workshop and Graduate Course - Posted 1st June 2022

24th ESGLD Workshop and Graduate Course
BOOKINGS NOW OPEN…

Dear ESGLD members,

The ESGLD Chairman, Local Organising Committee and Scientific Committee are happy to announce that Registration and Abstract submission for the 24th ESGLD Workshop and Graduate Course to be held face to face in Lancaster, UK between 7th – 11th September 2022 is now open!!!

Key meeting dates:
     7th – 8th September 2022: Graduate course
     8th – 11th September 2022: 24th ESGLD workshop

Please go to www.esgld.org to check your lab membership (100 Euros) is up-to-date for the period 2022/2023 – this allows ALL members of your lab to register for the 24th ESGLD Workshop and Graduate Course.

For details of this event and to register and submit your abstracts please follow this link BOOK NOW

Abstract submission deadline is 1st August 2022 – go direct using this ABSTRACT SUBMISSION LINK.

For any queries about the 24th ESGLD Workshop and Graduate Course please contact: tereza.andreou@manchester.ac.uk

We look forward to seeing you there!

Thank you for your continued collaboration and support,
Brian Bigger Chairman ESGLD chairman@ESGLD.org
Pim Pijnappel Treasurer ESGLD treasurer@ESGLD.org
Paul Saftig Secretary ESGLD secretary@ESGLD.org

Please email Chairman for website enquiries, Treasurer for payment enquiries and Secretary for new membership enquiries.

24th ESGLD Workshop & Graduate Course – UK 7th-11th September 2022 - Posted 1st May 2022

24th ESGLD Workshop & Graduate Course – UK 7th-11th September 2022

Dear ESGLD Members, as you may know it is the turn of the UK to hold the Bi-Annual ESGLD Workshop and Graduate Course. ESGLD Chair, Professor Brian Bigger and his University of Manchester Team are happy to announce that a date has been set for this event which will take place in the Northwest of England. Please hold the 7th – 11th of September 2022 in your diaries!

Valuable Lysosomal Data made available again! - Posted 1st April 2022

Valuable Lysosomal Data made available again!

Original lysosomal membrane proteomics data accessible again

Dear ESGLD Members we are happy to let you know that the original data in the proteomics paper on human lysosomal membrane by Bernd Schröder et al. (Integral and Associated Lysosomal Membrane Proteins. Traffic Volume8, Issue12 December 2007, Pages 1676-1686) is now available again.

These data became inaccessible after Blackwell’s, the original publishing house of Traffic, had been discontinued, for quite a long time. Thanks to the efforts of editors with Willey, the present publisher of Traffic, all the original data are accessible again. Just click on “Supporting information” at the end of the paper, if you ever wished to see them and could not to.

There is extensive original data including sequence of more than 13 thousands identified peptides and various data evaluations that are available. Please see link HERE:

MPSII Clinical Trial Project Manager - Posted 1st February 2022

MPSII Clinical Trial Project Manager

University of Manchester are seeking to appoint a full-time Clinical Trial Project Manager to work on an academic gene therapy clinical trials for MPSII patients. The posts is available for an immediate start for a fixed term period for 3 years.

The position offers an ideal opportunity for an enthusiastic, well-motivated individual to work as part of a multi-disciplinary team to manage and ensure the success of this gene therapy clinical trial in MPSII patients. This CTIMP trial require an ambitious Project Manager to manage the set up and day to day running’s of the trial, liaising with the sponsor, clinical site, managing CRO and other third parties.

The post holder will also support the development of other new and ongoing clinical trials within the group and provide administrative support in the submission of industrial funding bids, grant applications and support the set up and running of a GCP facility. The post holder will have excellent interpersonal, communication, IT, and organisational skills, will be able to work with minimal supervision, and will have experience within research, preferably in biological or medical sciences within a trial setting. Adherence to good clinical practice (GCP) is essential to this role, particularly with regard to data handling and record keeping.

As an equal opportunities employer we welcome applicants from all sections of the community regardless of age, sex, gender (or gender identity), ethnicity, disability, sexual orientation and transgender status. All appointments are made on merit.

For further detail please follow link HERE:

Commemoration Meeting Prof. Milan Elleder – 5th October 2021 - Posted 1st September 2021

Commemoration Meeting Prof. Milan Elleder – 5th October 2021

A Commemoration meeting is to be held on the 5th of October 2021 to honour the memory of Professor Milan Elleder. It has been 10 years since he passed away. The meeting information is in the invitation – please click the link below.

There will be a Keynote lecture from Dr. Marie T Vanier (INSERM, Lyon, France) – Milan Elleder, the Prague group and Niemann-Pick diseases. It will be a good opportunity to meet to honour the memory of Professor Elleder the way we think he would like. The majority of the presentations are going to be in Czech but the Keynote lecture from Dr Vanier will be in English at 11:15-12:30 (CEST) and this is the link to the live stream (https://bit.ly/setkanielleder).

Milan Elleder was a key ESGLD figure for several decades and has contributed substantially to the community. Also, Marie Vanier´s keynote tribute to his contributions to understanding and delineation of NPA/B and NPC will be quite exceptional and of major interest to “lysosomalists” of all ages.

Also attached is Milan Elleder´s obituary that was written by Martin Hrebicek and was distributed to ESGLD members in 2011.

elleder_invitation (Link to event Invitation)

orbituaryElleder (Link to Obituary written by Martin Hrebicek)

MPSIIIA and MPSII Clinical Trial Project Manager Roles x 2 – deadline 6/10/21 - Posted 1st September 2021

MPSIIIA and MPSII Clinical Trial Project Manager Roles x 2 – deadline 6/10/21

University of Manchester are seeking to appoint two full-time Project Managers to work on two academic gene therapy clinical trials for either MPSII or MPSIIIA patients. The posts are both available for an immediate start for a fixed term period until the 30th October 2024.

The position offers an ideal opportunity for an enthusiastic, well-motivated individual to work as part of a multi-disciplinary team to manage and ensure the success of this gene therapy clinical trial in MPSII or MPSIIIA patients. Both trials require an ambitious Project Manager to manage the day to day runnings of the trial, liaising with the Sponsor, Clinical site, managing CRO and other third parties.

You will also support the development of other new and ongoing clinical trials within the group and provide administrative support in the submission of industrial funding bids, grant applications and support the set up and running of a GCP facility. The post holder will have excellent interpersonal, communication, IT, and organisational skills, will be able to work with minimal supervision, and will have experience within research, preferably in biological or medical sciences. Adherence to good clinical practice (GCP) is essential to this role, particularly with regard to data handling and record keeping.

For More information please follow this HERE:

ESGLD Virtual Summer Meeting – Thanks and Awards - Posted 1st September 2021

ESGLD Virtual Summer Meeting – Thanks and Awards

A big thanks to everyone who took part in our recent ESGLD Summer Virtual Meeting. We had a great turnout and a particular thanks to all our excellent speakers who made it such a success.

Talks over the three days covered a broad spectrum of topics including lysosomal function, mechanisms of lysosomal disease and therapies and diagnosis. The ESGLD Scientific Committee had the difficult task of choosing four outstanding presentations. Three prizes were awarded for the best presentations from the selected abstracts and one prize for the best flash talk.

Awards for best selected abstract presented to:

Alessia Calcagni (Baylor College of Medicine ) – CLN3 protein is at the crossroad between the biosynthetic/secretory compartment and lysosomes
Malte Klüssendorf (University Medical Center, Hamburg-Eppendorf) Cytosoplasmic retention of acetylated transcription factor EB
Dominic Winter (University of Bonn) Characterization of Lysosomal Protein Interactions and Structures by Cross Linking Mass Spectrometry

Award for best Flash Talk/Virtual Poster presented to:

S.L.M. in ‘t Groen (Erasmus MC) – Uncovering pathological mechanisms in Pompe disease using a 3D-skeletal-muscle-on-a-chip system.

Contact ESGLD

For further information please contact:

Nicolina Cristina Sorrentino, PhD
Telethon Institute of Genetics and Medicine
Via Campi Flegrei 34
80078 Pozzuoli (NA), Italy
Phone: +39 081 1923 0649
Fax: +39 081 1923 0651

secretary@esgld.org

Contact Us